Literature DB >> 22960635

Che-ating death: CHE1/AATF protects from p53-mediated apoptosis.

James G Jackson1, Guillermina Lozano.   

Abstract

The tumour suppressor p53 directs cells towards different fates depending on the cell type and the stimulus. The decision to direct a cell towards apoptosis rather than cell-cycle arrest or senescence has important implications for tumour suppression in normal cells and drug response in tumour cells. Cells that undergo senescence and growth arrest can persist and contribute to organismal ageing (Campisi, 2005), or they can contribute to tumour relapse (Jackson et al, 2012). In this issue of The EMBO Journal, Höpker et al (2012) show in a comprehensive study that the RNA PolII binding protein CHE1/AATF is a factor that determines the fate of cells that have activated the p53 pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22960635      PMCID: PMC3474930          DOI: 10.1038/emboj.2012.258

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  15 in total

1.  ASPP proteins specifically stimulate the apoptotic function of p53.

Authors:  Y Samuels-Lev; D J O'Connor; D Bergamaschi; G Trigiante; J K Hsieh; S Zhong; I Campargue; L Naumovski; T Crook; X Lu
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

2.  PUMA, a novel proapoptotic gene, is induced by p53.

Authors:  K Nakano; K H Vousden
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

Review 3.  The role of p53 in determining sensitivity to radiotherapy.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Nat Rev Cancer       Date:  2003-02       Impact factor: 60.716

Review 4.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

5.  hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.

Authors:  Abdeladim Moumen; Philip Masterson; Mark J O'Connor; Stephen P Jackson
Journal:  Cell       Date:  2005-12-16       Impact factor: 41.582

Review 6.  Predicting response to cancer chemotherapy: the role of p53.

Authors:  M Weller
Journal:  Cell Tissue Res       Date:  1998-06       Impact factor: 5.249

7.  p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.

Authors:  S Fan; W S el-Deiry; I Bae; J Freeman; D Jondle; K Bhatia; A J Fornace; I Magrath; K W Kohn; P M O'Connor
Journal:  Cancer Res       Date:  1994-11-15       Impact factor: 12.701

8.  Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.

Authors:  Yi Tang; Jianyuan Luo; Wenzhu Zhang; Wei Gu
Journal:  Mol Cell       Date:  2006-12-28       Impact factor: 17.970

Review 9.  Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.

Authors:  Judith Campisi
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

10.  p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53.

Authors:  K Oda; H Arakawa; T Tanaka; K Matsuda; C Tanikawa; T Mori; H Nishimori; K Tamai; T Tokino; Y Nakamura; Y Taya
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

View more
  2 in total

1.  MicroRNA-663 antagonizes apoptosis antagonizing transcription factor to induce apoptosis in epithelial cells.

Authors:  M R Benakanakere; J Zhao; L Finoti; R Schattner; M Odabas-Yigit; D F Kinane
Journal:  Apoptosis       Date:  2019-02       Impact factor: 5.561

2.  Che1/AATF interacts with subunits of the histone acetyltransferase core module of SAGA complexes.

Authors:  Gizem Caliskan; Ikbal C Baris; Ferhan Ayaydin; Melanie J Dobson; Muge Senarisoy; Imre M Boros; Zeki Topcu; Sevil Zencir
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.